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Endocannabinoids control hippocampal inhibitory synaptic transmission through activation of presynaptic CB1 receptors. During
depolarization-induced suppression of inhibition (DSI), endocannabinoids are synthesized upon postsynaptic depolarization. The en-
docannabinoid 2-arachidonoylglycerol (2-AG) may mediate hippocampal DSI. Currently, the best studied pathway for biosynthesis of
2-AG involves the enzyme diacylglycerol lipase (DAGL). However, whether DAGL is necessary for hippocampal DSI is controversial and
was not systematically addressed. Here, we investigate DSI at unitary connections between CB1 receptor-containing interneurons and
pyramidal neurons in CA1.We found that the novel DAGL inhibitor OMDM-188, as well as the established inhibitor RHC-80267, did not
affect DSI. As reported previously, effects of the DAGL inhibitor tetrahydrolipstatin depended on the application method: postsynaptic
intracellular application left DSI intact, while incubation blockedDSI.We show that all DAGL inhibitors tested block slow self-inhibition
inneocortical interneurons,which involvesDAGL.Weconclude thatDAGL is not involved inDSI at unitary connections inhippocampus.
Introduction
Endocannabinoids mediate both short- and long-term plasticity
atmany synapses in the brain. The first formof synaptic plasticity
in which endocannabinoids were shown to be involved is hip-
pocampal depolarization-induced suppression of inhibition
(DSI) (Wilson and Nicoll, 2001). Hippocampal DSI occurs at a
subset of inhibitory synapses onto pyramidal neurons coming
from CB1 receptor (CB1R)-containing interneurons. At these
synapses, a postsynaptic depolarization leads to calcium-
dependent synthesis of endocannabinoids, which subsequently
travel to the presynaptic inhibitory terminal. Here, endocannabi-
noids activate the G-protein coupled CB1R, thereby reducing
presynaptic release probability for tens of seconds. The endocan-
nabinoid 2-arachidonoyl glycerol (2-AG) (Sugiura et al., 1995)
has been proposed to mediate hippocampal DSI, since inhibiting
2-AG degradation increases the duration of DSI (Kim and Alger,
2004; Makara et al., 2005; Hashimotodani et al., 2007). However,
sn-1-diacylglycerol lipase (DAGL) , the major enzyme cata-
lyzing 2-AG formation in the adult brain (Bisogno et al., 2003)
has not been found opposite symmetrical, GABAergic synapses
in hippocampus (Katona et al., 2006). Furthermore, studies in
which DAGLs have been targeted pharmacologically reported
conflicting results. Blocking these enzymes pharmacologically
suppresses hippocampal DSI in some studies (Hashimotodani et
al., 2007) but not in others (Chevaleyre and Castillo, 2003;
Edwards et al., 2006; Szabo et al., 2006). So far, the only study
showing pharmacological evidence for DAGL involvement in
hippocampal DSI was performed on cultured neurons. This
raises the question whether DAGL is involved in hippocampal
DSI at intact synapses. Here, by using three chemically different
DAGL inhibitors, we have investigated DAGL involvement in
hippocampal DSI at unitary connections between CB1R-
containing interneurons and CA1 pyramidal neurons.
Materials andMethods
Slice preparation. All experiments were approved by the Animal Ethical
Committee of the VU University Amsterdam, in accordance with
Dutch and European law. For DSI experiments, 14- to 21-d-old wild-
type C57Bl6 mice or CB1R
/ mice (Marsicano et al., 2002) were
decapitated. Transverse hippocampal slices (300 m) were sectioned
in ice-cold solution containing (mM): 126 NaCl, 3 KCl, 10 glucose, 26
NaHCO3, 1.2 NaH2PO4, 1 CaCl2, and 3 MgCl2 (carboxygenated with
5% CO2/95% O2). For slow self-inhibition (SSI) experiments, sagittal
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slices containing somatosensory cortex were cut from 21- to 28-d-old
FVB-Tg(GadGFP) 45704Swn/J mice expressing EGFP under control of
the mouse Gad1 gene promoter (The Jackson Laboratory stock no.
003718), thereby labeling a subset of somatostatin-positive interneurons
in hippocampus and neocortex (Oliva et al., 2000). Slices were main-
tained at 33°C for 30 min and recorded at room temperature
(2022°C) in a similar solution, but now with 2 mM CaCl2 and 2 mM
MgCl2.
Paired recordings of CB1R-containing interneurons and CA1 pyramidal
neurons. Cellular recordings were performed from 2–6 neurons simulta-
neously using borosilicate glass pipettes with resistance of 3–5M, con-
taining the following (in mM): 70 K gluconate, 70 KCl, 4 Mg-ATP, 4
phosphocreatine, 0.4 GTP, 0.5 EGTA and 10 HEPES (pH 7.3, KOH). In
synaptically connected neurons, suprathreshold stimulation of the pre-
synaptic interneuron evoked a GABAAR mediated IPSP/IPSC in the
postsynaptic CA1 pyramidal neuron. Because of the high intracellular
chloride concentration, IPSCs were observed as inward currents, while
IPSPs were depolarizing. Presynaptic cells were stimulated with a pair of
two suprathreshold current pulses (at 10 Hz). Trains were delivered
with intervals of 5 s. Recording and stimulus delivery was performed
using standard electrophysiological equipment.
SSI recordings in neocortical interneurons. For experiments on SSI,
EGFP expressing interneurons in somatosensory cortex were selected
using an UV light source and fluorescence imaging. Extracellular and
intracellular solutions were similar as for paired recordings, but to ex-
clude contributions from synaptic conduc-
tances DNQX (10 M), GABAzine (100 M),
and DL-AP5 (100 M) were added to the extra-
cellular solution.
Immunohistochemistry. Some recorded in-
terneurons were filled with biocytin (0.5%),
and slices were fixed and resliced after record-
ing. Sections were stained using the antibodies
goat-anti-streptavidin Alexa Fluor 488 conju-
gate (1:200) and the primary antibody rabbit-
anti- CB1R (diluted 1:1000 in TBS-TX) (Tsou
et al., 1998). In a second step, sections were
incubated with the secondary antibody Alexa
Fluor 594 goat anti-rabbit IgG (1:200). Colo-
calization between biocytin and CB1R was de-
termined using a Leica confocal laser-scanning
microscope (Leica), the Huygens system (Sci-
entific Volume Imaging), and the Amira iso-
surface module (Konrad Zuse Center for
Information Technology, Berlin, Germany).
Care was taken to prevent false positives, in-
complete signal separation and crosstalk of
dyes. Neuron reconstructions were performed
under an up-right microscope (Leica) using a
40 objective with Neurolucida software
(Neurolucida, MicroBrightField).
Chemicals. Of tetrahydrolipstatin (THL),
RHC-80267 (Sigma-Aldrich) and OMDM-188
(Ortar et al., 2008) appropriate stock solutions
were prepared in DMSO (Final concentration
0.2%). Slice-incubation was done in the slice
chamber for at least 30 min before recordings
started, with the same compound concentra-
tion present extracellularly. For intracellular
application, intracellular equilibration was al-
lowed for at least 20 min after whole-cell
break-in (see Figs. 3, 4). Vehicle controls with
intracellular or extracellularDMSOwere inter-
leaved with normal control experiments. Be-
cause we observed no vehicle effects, all control
experiments were grouped.
Analysis. All analysis was done using custom
written procedures in Igor Pro (Wavemetrics).
Statistical analysis was done either using two-
sided Student’s t test (for single comparisons;
  0.05), or ANOVA with post hoc Dunnett’s test (for multiple com-
parisons;  0.05).
Results
Simultaneous whole-cell recordings were made from CA1 py-
ramidal neurons and interneurons located in stratum radia-
tum, close to the border with stratum pyramidale (Fig. 1). Cell
bodies of selected interneurons had a multipolar appearance
and their firing pattern upon current injection showed con-
siderable spike-frequency adaptation (Fig. 1C). To confirm
the presence of CB1Rs in the studied interneurons, we used
biocytin staining and immunostaining for the CB1R in a subset
of interneurons (Fig. 1A,B). All interneurons showed sub-
stantial colocalization of biocytin and CB1R immunoreactivity
in axons (n  5/5) (Fig. 1B).
Inhibitory connections were activated by evoking two action
potentials (APs) at 10 Hz in the interneuron, while recording
IPSCs in the CA1 pyramidal neuron (voltage-clamped at 70
mV) (Fig. 1D). In cell pairs showing an inhibitory synaptic con-
nection we tested for the presence of DSI. Two APs were evoked
in the interneuron once every 5 s (0.2 Hz). After recording 50
control responses, the subsequent 50 responses were each pre-
Figure 1. Properties of CB1R-containing interneuron to CA1 pyramidal neuron pairs. A, Reconstruction of the axonal (green)
anddendritic (black) tree of a biocytin-filled CA1basket interneuronwith its soma (black)within stratum radiatum (str. rad.), close
to the border with stratum pyramidale (str. pyr.). B, Fluorescent image of part of the biocytin filled axon in green (top), CB1R
staining in red (middle), andmerged image (bottom). All images are from the same focal plane. Note the colocalization of biocytin
and CB1R antibody staining (white arrowheads). C, AP firing in response to current injection of a CB1R-containing interneuron
(green) and a CA1 pyramidal neuron (blue). D, Example trace of APs evoked by two short current injections into the interneuron
(green) and the IPSC response in a postsynaptic pyramidal neuron voltage clamped at70mV (blue; average of 50 sweeps) of the
same cell pair as in C.
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ceded by a depolarizing step (1 s to 0 mV)
to the postsynaptic pyramidal cell (depo-
larization period) (Fig. 2A). For IPSCs
evoked after such a depolarizing step, the
IPSC amplitude was reduced to 36.0 
2.6% of control (Fig. 2A–C) ( p 0.0001;
n  7), meaning that there was 64.0 
2.6% DSI. Amplitude reduction was ac-
companied by a strong increase in synap-
tic failure rate (Fig. 2D) (control 30.0 
4.6%; depolarization 49.4  5.1%; p 
0.024). After the depolarization period,
both IPSC amplitude and failure rate par-
tially recovered, respectively to 76.3 
3.1% and 37.1 5.0% (Fig. 2A–D).
The increase in failure rate during the
depolarization period is in support of a
presynaptic locus of suppression of inhi-
bition. Analysis of the coefficient of varia-
tion (CV) of the IPSC amplitudes (Faber
and Korn, 1991) showed that the ratio be-
tween CV2 during DSI versus CV2 under
control was proportional to the relative
change in synaptic amplitude (Fig. 2E)
(averaged CV2DSI/CV
2
control: 0.38  0.03;
amplitude ratio: 0.36 0.03), confirming
that the modulation is presynaptic in ori-
gin. In CB1R knock-out (CB1R
/) mice,
we did not observe a significant reduc-
tion in IPSC amplitude during the de-
polarization period, and failure rate was
unaffected (supplemental Fig. S1, avail-
able at www.jneurosci.org as supplemen-
tal material). Together, these findings
suggest that DSI at these unitary synapses
occurs through a decreased presynaptic
release probability by CB1R activation.
Activity-dependent endocannabinoid
synthesis in several brain regions depends
on the DAGL enzymatic activity (Melis et
al., 2004; Safo and Regehr, 2005; Szabo et
al., 2006). To test for the involvement of
DAGLs in hippocampal DSI, we used
several DAGL inhibitors. Slices were incubated with the novel
potent DAGL inhibitor OMDM-188 (2 M; Ortar et al., 2008)
for at least 30 min before commencing paired recordings in the
presence ofOMDM-188. Under these conditions, significantDSI
was still observed (amount ofDSI: 46.2 5.3%; n 6; p 0.016)
(Fig. 3A), and was accompanied by an increase in failure rate
(control: 51.7  1.6%; depolarization: 67.7  2.2%; p  0.03)
(Fig. 3A). The amount of DSI did not differ significantly from
control conditions ( p 0.05) (Fig. 3F). Similarly, slices incu-
bated and recorded with the established DAGL inhibitor RHC-
80267 (50–70M) also showed significantDSI (87.5 2.4%; n
5; p  0.009) (Fig. 3B), and an increase in failure rate (control:
54.0 4.7%; depolarization: 92.0 0.6%; p 0.03) (Fig. 3B).
Recently, several studies have reported opposing effects of
extracellular application of the DAGL inhibitor THL on
hippocampal DSI (Szabo et al., 2006; Edwards et al., 2008; Hashi-
motodani et al., 2008). It has been shown that intracellular appli-
cation of low concentrations of THL is very effective at inhibiting
DAGL activity in striatum (500 nM) (Melis et al., 2004) and cer-
ebellum (2 M) (Safo and Regehr, 2005). Therefore, we added
THL (5 M) to the intracellular solution of the postsynaptic py-
ramidal neuron, without applying THL extracellularly. To allow
intracellular diffusion of THL the depolarization protocol was
started at least 20 min after establishing the whole-cell configu-
ration at the pyramidal neuron. Intracellularly applied THL did
not affect DSI (70.9  1.6%; n  15; p  0.02) (Fig. 3C) (com-
pared to control DSI: p  0.05) (Fig. 3F). Accordingly, failure
rate significantly increased upon depolarization (control: 24.9
1.6%; depolarization: 66.8  2.0%; p  0.001) (Fig. 3C). Even
with a 1 h waiting period for intracellular THL diffusion, DSI was
clearly observed (Fig. 3E), suggesting that the ineffectiveness of
intracellular THL was not due to incomplete intracellular diffu-
sion. Surprisingly, when slices were incubated extracellularly
with higher concentrations of THL (10 M), DSI was abolished
(17.2 2.1%; n 6; p 0.10) (Fig. 3D), and failure rate was not
affected by depolarization (control: 51.8 3.8%; depolarization:
51.1  3.4%; p  0.86) (Fig. 3D). To assess whether extracellu-
larly appliedTHL affectedCB1R signaling downstreamof theCB1
receptor, we tested the effect of THL on the suppression of IPSCs
by the CB1R agonist WIN55,212-2 (2 M). IPSC suppression by
Figure 2. DSI in connected interneuron to CA1 pyramidal neurons. A, Left, Recording configuration. Right, Postsynaptic IPSC
responses to presynaptic stimulation in connected interneuron to CA1 pyramidal neurons under control conditions (control),
following depolarization of the pyramidal neuron (depolarization) and during recovery from depolarization period (recovery).
Traces show10 individual IPSC responses (gray traces) aswell as theaverage responseof 50 subsequent responses (black traces) for
each condition. B, IPSC amplitudes during the same experiment as in A. Each dot represents a single IPSC amplitude. Lines show
average of 50 control responses, 50 responses that were each preceded by a depolarization, and 50 responses during recovery.
C, Average normalized IPSC amplitudes of DSI experiments (n 7). For each experiment, IPSC amplitudeswere normalized to the
average IPSCamplitude in control. Open circles showaverageamplitude for each timepoint. Closed circles showaverageamplitude
of the10preceding timepoints. Lines showaveraged IPSCamplitudeduring control, followingdepolarization andduring recovery.
D, Failure rate during control, following depolarization and during recovery. Open circles and dotted lines represent individual
experiments; closed circles and solid lines show averaged failure rate for each condition. E, CV analysis. Graph shows the relative
changewith DSI in coefficient of variance (CV, y-axis) plotted against the averaged change in IPSC amplitude (x-axis). Open circles
show individual experiments, closed circle shows the average.
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WIN55,212-2was unaffected in slices incubated inTHL, showing
that THL incubation did not interfere with CB1R signaling down
stream of the receptor (supplemental Fig. S2, available at www.
jneurosci.org as supplemental material).
These observations raise the possibility that the other treat-
ments were not effective in inhibiting DAGLs due to suboptimal
experimental conditions such as lack of cell penetration. To ex-
clude this possibility, we used the above procedures and inhibi-
tors to block DAGLs in the well-established
phenomenon of SSI of neocortical inter-
neurons (Bacci et al., 2004). SSI is induced
by repetitive AP firing of somatostatin-
positive low-threshold spiking (LTS) in-
terneurons in neocortex (Fig. 4). It is
triggered by endocannabinoid-mediated
activation of postsynaptic CB1Rs, which in
turn activate a prolonged K	 conductance.
Recently, it was shown that DAGL inhibi-
tion effectively abolishes SSI (Marinelli et
al., 2008).Wemadewhole-cell recordingsof
interneurons in mice expressing EGFP in
somatostatin-positive interneurons (Oliva
et al., 2000) (Fig. 4A). Upon hyperpolariz-
ing current steps these neurons showed a
clear rebound depolarization that regu-
larly induced a rebound AP (Fig. 4A),
characteristic of LTS interneurons. After
recording resting membrane potential for
several minutes, LTS interneurons were
stimulated with 10 trains of 60 APs at 50
Hz each (Marinelli et al., 2008). This stim-
ulation induced a clear, long-lasting drop
in membrane potential (SSI; 
Vm:
4.30 0.96mV;n 12; p 0.001) (Fig.
4B). SSI was absent in CB1R
/ mice,
showing that it is mediated by CB1Rs
(supplemental Fig. S3, available at www.
jneurosci.org as supplemental material).
All pharmacological interventions reduc-
ing DAGL-activity effectively blocked
SSI (Fig. 4,C–F). When slices were incu-
bated and recorded in OMDM-188 (2
M), SSI was absent (
Vm: 0.79 
0.76 mV; n  8; p  0.33) (Fig. 4C).
Incubation with RHC-80267 (70 M)
also effectively blocked SSI (
Vm:
0.63  1.34 mV; n  5; p  0.66) (Fig.
4D). Finally, intracellular application of
THL (5 M) also effectively blocked SSI
(
Vm: 0.35  0.98 mV; n  6; p 
0.74) (Fig. 4E).
Therefore, we conclude that the lack of
effect of DAGL inhibitors on DSI at the in-
terneuron to CA1 pyramidal neuron uni-
tary connections that we studied was not
due to suboptimal experimental conditions.
Taken together, our data suggest thatDSI at
these unitary connections in hippocampus
occurs without the involvement of DAGL
activity.
Discussion
Biosynthetic pathways controlling endo-
cannabinoid formation in hippocampal
DSI have remained unclear. We systematically addressed involve-
ment of DAGLs in DSI at identified unitary synaptic connections.
We show that several known DAGL inhibitors do not affect DSI at
these hippocampal synapses, while they abolish SSI in neocortical
interneurons (Fig. 4), a process known to require DAGL activity
(Marinelli et al., 2008). Our findings strongly suggest that DAGL is
not involved in hippocampal DSI.
Figure 3. The effect of DAGL inhibitors on DSI. A, Left, Postsynaptic IPSC responses to presynaptic stimulation in
connected interneuron and CA1 pyramidal neuron incubated and recorded in the DAGL inhibitor OMDM-188 (2M). Traces
show average response of 50 subsequent responses for each condition. Middle, Average normalized IPSC amplitudes of all
experiments in OMDM-188 (n 6), displayed as in Fig. 2C. Right, Failure rate during control, following depolarization and
during recovery for experiments in OMDM-188, displayed as in Fig. 2 D. B, Same as in A, but now for experiments on slices
incubated and recorded in the DAGL inhibitor RHC-80267 (70M; n 5). C, Same as in A, B, but now for experiments in
which THL (5M) was added to the intracellular solution of the postsynaptic pyramidal neuron (n 15). D, Same as in A,
B, but now for experiments on slices incubated and recorded in the DAGL inhibitor THL (10M; n 6). E, The amount of
DSI observed in experiments in which THL (5 M) was added to the intracellular solution of the postsynaptic pyramidal
neuron versus the time waited after whole cell on the postsynaptic pyramidal neuron (same experiments as in C). Dotted
line shows the amount of DSI observed under control conditions. F, Amount of DSI observed under different conditions.
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Recently, studies have reported oppos-
ing effects of the DAGL inhibitor THL on
DSI (Szabo et al., 2006; Edwards et al.,
2008; Hashimotodani et al., 2008). Intra-
cellular application of THL effectively in-
hibits DAGL activity in VTA, cerebellum,
and neocortex (Melis et al., 2004; Safo and
Regehr, 2005; Marinelli et al., 2008). We
found that intracellular postsynaptic ap-
plication of THL did not affect DSI. This
lack of effect is unlikely to be due to exper-
imental conditions, because intracellular
THL application successfully blocked SSI,
confirming a previous report byMarinelli
et al. (2008). Therefore, these results con-
firm the findings with other DAGL inhib-
itors, and rule out involvement of DAGL
in hippocampal DSI. This raises the ques-
tion by what mechanism extracellular
THL application blocks hippocampal DSI
(Edwards et al., 2008; Hashimotodani et
al., 2008). Hashimotodani et al. (2008)
and Szabo et al. (2006) ruled out indirect
effects of THL on either CB1R signaling or
calcium influx necessary for DSI induc-
tion. Likewise, we show that slice incuba-
tion with THL does not affect CB1R
signaling (supplemental Fig. S2, available
at www.jneurosci.org as supplemental
material). At present, the mechanism by
which extracellular THL blocks hippocam-
pal DSI remains elusive. Given the absence
of effects of OMDM-188, RHC-80267, and
intracellular THL onDSI, we argue that ex-
tracellular THLdoes not blockDSI through
inhibition of DAGL.
A recent study showed that hippocam-
pal DSI during cholinergic receptor acti-
vation requires signaling by nitric oxide (NO) (Makara et al.,
2007). This opens the possibility that under these conditions en-
docannabinoid synthesis takes place outside of the postsynaptic
neuron, perhaps in the presynaptic terminal, and that NO is the
messenger emanating from the postsynaptic neuron. If the
downstream target of NO would be sensitive to THL, this might
explain why extracellular application of THL blocks DSI, while
postsynaptic application is ineffective. However, in the same
study from Makara et al. (2007) it was shown that NO is not
involved in DSI in the absence cholinergic receptor activation.
In agreement with this, we find that DSI at unitary connec-
tions, in the absence of cholinergic receptor activation, is not
affected by incubation with the NO-synthase inhibitor N-
Nitro-L-arginine methyl ester (supplemental Fig. S4, available
at www.jneurosci.org as supplementalmaterial). Therefore,NO in-
volvement cannot explain the discrepancy between the effects of
extracellular and postsynaptic THL application in our experiments.
It has been suggested that DSI might involve a pre-formed
2-AG pool (Edwards et al., 2006), and that DAGLs are involved in
filling this pool, not in the actual DSI process. However, when
blockingDAGLs,we did not observe a reduction in the amount of
DSI during 50 subsequent depolarizations, although this would
be expected when depleting a pre-formed pool of 2-AG. There-
fore, if DSI involves a pre-formed pool of 2-AG, this poolmust be
quite substantial and stable.
Recent studies suggested that 2-AG, and not anandamide, is
the endocannabinoid mediating hippocampal DSI. This conclu-
sion was based on the ability of inhibitors of monoacylglycerol
lipase, the enzyme that breaks down 2-AG, to prolong hippocam-
pal DSI (Makara et al., 2005; Hashimotodani et al., 2007). Fur-
thermore, inhibition of fatty-acid amide hydrolase, the enzyme
responsible for anandamide breakdown, does not affect the time
course of hippocampal DSI (Kim and Alger, 2004; Makara et al.,
2005;Hashimotodani et al., 2007).However, while studies ofDAGL
distribution in hippocampus have shown that sn-1-DAGL- is per-
fectly positioned for production of 2-AG as retrogrademessenger at
excitatory synapses (Katona et al., 2006; Yoshida et al., 2006), sn-1-
DAGL-was not found opposite symmetrical, GABAergic synapses
(Katona et al., 2006). Together with our results, this suggests that
sn-1-DAGL- is not involved in DSI at inhibitory synapses in hip-
pocampus. This may suggest that 2-AG is produced by different
mechanisms at these synapses, involving another, hitherto un-
known, synthesis pathway, such as the lysophosphatidic acid-
dependent route (Nakane et al., 2002). Alternatively, it may suggest
that 2-AG is not the endocannabinoid mediating DSI at unitary
inhibitory synaptic connections in hippocampus.
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